Amid growing concerns about the 4th epidemic, including the spread of the corona 19 mutant virus, foreign immigrants are waiting at a distance at Incheon International Airport in Yeongjong Island on the 5th. Yeongjongdo = Yonhap News
Experts have mixed judgments on whether to vaccinate the elderly with the AstraZeneca (AZ) vaccine, the UK-made Corona 19 vaccine. On the 5th, the Central Pharmacist Review Committee (Yakshin Committee), an expert advisory body of the Ministry of Food and Drug Safety, announced on the 5th that it is possible to approve the item under the condition of submitting the results of the ongoing clinical trial for the AZ vaccine. However, regarding vaccinations over the age of 65, the judgment was reserved, saying, “It should be discussed at the Vaccination Committee of the Korea Disease Control Agency.” The Yaksim Committee “means that the data on the elderly are limited, so use carefully until the effectiveness is verified. ”Added.
It is different from the conclusion of the Korea Food and Drug Administration’s verification advisory group that said on the 1st that “the majority of experts cannot rule out vaccinations for those over 65 years of age.” The reason why experts are disagreed is that each country’s judgment on vaccination for the elderly is different. The European Union and the UK have approved the use of this vaccine to all adults, while Germany and France recommend only vaccinations to those under the age of 65.
The AZ vaccine, which is scheduled to be introduced at the end of this month, relatively early compared to other vaccines, is the welcome to the’vaccination campaign’ that will target 33 million people within the year. The effectiveness of this vaccine depends on the overall reliability of vaccination. In fact, as the controversy continues, there is an atmosphere that some elderly people will not get the AZ vaccine recently. The confusion that will arise if the rejection of vaccination is followed by an effect problem is predictable. When deciding whether to vaccination for the elderly, the government should thoroughly follow the scientific basis for its effectiveness. It is necessary to more closely monitor overseas cases.
The government has set up a vaccination strategy that puts the principle of vaccination on the minimization of deaths, and that vaccinations for the elderly with a high rate of seriousness and seriousness are conducted in the second quarter. However, I hope that the principle should not be revised to rule out the postponement of vaccination for the elderly and the introduction of other non-controversial vaccines. This is the time when a message is needed that the government is most concerned with the safety and effectiveness of the vaccine, rather than pushing the vaccination schedule.
News directly edited by the Hankook Ilbo is also available on Naver.
